SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-016255
Filing Date
2023-05-08
Accepted
2023-05-08 07:05:04
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20230331.htm   iXBRL 10-Q 838479
2 EX-31.1 fhtx-20230331xex311.htm EX-31.1 10349
3 EX-31.2 fhtx-20230331xex312.htm EX-31.2 10328
4 EX-32.1 fhtx-20230331xex321.htm EX-32.1 4394
5 EX-32.2 fhtx-20230331xex322.htm EX-32.2 4379
  Complete submission text file 0001628280-23-016255.txt   4074514

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20230331.xsd EX-101.SCH 30294
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20230331_cal.xml EX-101.CAL 49249
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20230331_def.xml EX-101.DEF 113995
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20230331_lab.xml EX-101.LAB 367814
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20230331_pre.xml EX-101.PRE 226669
50 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20230331_htm.xml XML 610369
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 23895817
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences